Happy New Year! Please be advised that in-transit patient samples will be held by the carrier on Jan. 1, and received by our lab the next day. Kit orders placed on Dec. 31 and Jan. 1 will be sent on Jan. 2. Our genetic counseling services, client services, and billing services will be unavailable on Jan. 1; please leave us a message at 888-729-1206 or support@genedx.com and we will respond when we return.
Chief Medical Officer
Paul Kruszka is Chief Medical Officer of GeneDx, with responsibility for leading genomic research in rare diseases and promoting access to genomic medicine.
Paul is a board-certified clinical geneticist who uses genomic and precision medicine to enhance the delivery of healthcare to individuals with rare diseases. Paul’s career is motivated by the idea that genetic technology can be used to have a beneficial impact on people’s lives and that there are still many challenges to implementing genomic medicine.
Prior to working at GeneDx, Paul spent a decade at the National Institutes of Health conducting genomic research and taking care of individuals with rare genetic diseases. He is credited with the clinical and molecular delineation of multiple novel genetic conditions.
After attending medical school at the University of Michigan, Paul completed a family medicine residency at the University of Virginia. He also completed a clinical genetics residency at the National Human Genome Research Institute at the National Institutes of Health.
